VAERS reports by lot

Janssen (J&J) COVID-19 lot 1820096: VAERS reports

118 VAERS reports list lot 1820096 as a Janssen (J&J) COVID-19 vaccine, received between 2021-06-03 and 2022-10-06. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
118
Reports
9%
Marked serious
1
With a death outcome
14
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological10328%
General / Systemic (non-local)5715%
Cardiac / Cardiovascular4111%
Gastrointestinal3810%
Dermatological (non-injection-site)308%
Musculoskeletal298%
Injection-site / Local reaction216%
Respiratory205%
Allergic / Anaphylactic123%
Psychiatric / Neuropsychiatric82%
Reproductive / Menstrual62%
Thrombotic / Hematological21%
Autoimmune / Immune-mediated10%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York20
Illinois12
California12
Florida10
Michigan8
Pennsylvania7
New Jersey6
Texas5
Minnesota4
Georgia4
Ohio2
Mississippi2

Reports by month received

2021-0631
2021-0724
2021-0816
2021-0913
2021-1018
2021-112
2021-124
2022-013
2022-022
2022-031
2022-041
2022-051
2022-081
2022-101

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.